| [1] |
中华人民共和国国家统计局.2010 年第六次全国人口普查主要数据公报(第1 号)[EB/OL]. [2012-12-04]. http:/ /www.stats.gov.cn/tjfx/jdfx/t20110428_402722253.htm.
|
| [2] |
U.S. Social Security Administration. Age to receive full social security retirement benefits[EB/OL]. [2012-12-04]. http:/ /www.socialsecurity.gov/retire2/retirechart.htm.
|
| [3] |
Picton C. Report on the world assembly on ageing— Vienna 1982[J]. Australas J Ageing,1982,1(4):13-14.
|
| [4] |
WHO Centre for Health Development (Kobe, Japan). A glossary of terms for community health care and services for older persons [R]/ / WHO Kobe Centre ageing and health technical report,v.5. [2012-12-06]. http:/ /apps. who. int/iris/bitstream/10665/68896/1/WHO_WKC_Tech.Ser._04.2.pdf.
|
| [5] |
Howlader N, Noone AM, Krapcho M,et al. SEER cancer statistics review 1975-2010 [EB/OL].[2013-01-09]. http:/ /seer. cancer. gov/csr/1975_2010/results_merged/sect_04_breast.pdf.
|
| [6] |
Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v2.0,Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [EB/OL]. [2013-01-09]. http:/ /globocan. iarc. fr/Age-specific-curves1p1c.asp? groupp=1&selection_pop=64990&Text-p=European+Union+%28EU-27%29&groupc=1&selection_cancer=3142&Text-c=cancer&female=2&incidence=1&orientation=1&window= 1&grid = 1&line = 2&submit =% 26% 23160%3BExecute%26%23160%3B.
|
| [7] |
黄哲宙,陈万青,吴春晓,等. 中国女性乳腺癌的发病和死亡现况——全国32 个肿瘤登记点2003-2007 年资料分析报告[J]. 肿瘤,2012,32(6):435-439.
|
| [8] |
National Cancer Institute. SEER cancer statistics review 1975-2008[EB/OL]. [2013-01-09]. http:/ /seer. cancer. gov/csr/1975_2008/results_merged/sect_04_breast.pdf.
|
| [9] |
American Cancer Society. Breast cancer facts & figures 2011-2012[M]. Atlanta: American Cancer Society, Inc.,2013:6.
|
| [10] |
Ali AM, Greenberg D, Wishart GC, et al. Patient and tumor characteristics, management, and age-specific survival in women with breast cancer in the East of England[J]. Br J Cancer,2011,104(4):564-570.
|
| [11] |
Bastiaannet E, Liefers GJ, de Craen AJ, et al. Breast cancer in elderly compared to younger patients in the Netherlands:stage at diagnosis,treatment and survival in 127 805 unselected patients[J]. Breast Cancer Res Treat,2010,124(3):801-807.
|
| [12] |
杨名添, 戎铁华,黄植蕃,等.可手术乳腺癌6263 例临床分析[J]. 癌症,2005,24(3):327-331.
|
| [13] |
Tang J,Wu CC,Xie ZM,et al. Comparison of clinical features and treatment outcome of breast cancers in young and elderly Chinese patients[J]. Breast Care (Basel),2011,6(6):435-440.
|
| [14] |
Ma CD, Zhou Q, Nie XQ,et al. Breast cancer in Chinese elderly women: pathological and clinical characteristics and factors influencing treatment patterns[J]. Crit Rev Oncol Hematol,2009,71(3):258-265.
|
| [15] |
Gennari R,Curigliano G,Rotmensz N,et al. Breast carcinoma in elderly women:features of disease presentation,choice of local and systemic treatments compared with younger postmenopausal patients [J]. Cancer,2004,101(6):1302-1310.
|
| [16] |
Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer[J]. J Natl Cancer Inst,2000,92(7):550-556.
|
| [17] |
Colleoni M, Rotmensz N, Robertson C, et al. Very young women(＜35 years) with operable breast cancer: features of disease at presentation[J]. Ann Oncol,2002,13(2):273-279.
|
| [18] |
de Munck L, Schaapveld M, Siesling S, et al. Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands[J]. Breast Cancer Res Treat,2011,129(1):229-233.
|
| [19] |
Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer[J]. Ann Intern Med,1994,120(2):104-110.
|
| [20] |
Biganzoli L, Wildiers H, Oakman C,et al. Management of elderly patients with breast cancer:updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)[J]. Lancet Oncol,2012,13(4):e148-160.
|
| [21] |
Alderman AK,Bynum J,Sutherland J,et al. Surgical treatment of breast cancer among the elderly in the United States[J].Cancer,2011,117(4):698-704.
|
| [22] |
Elkin EB, Hurria A, Mitra N, et al. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based,observational cohort[J]. J Clin Oncol,2006,24(18):2757-2764.
|
| [23] |
Giordano SH, Duan Z, Kuo YF, et al. Use and outcomes of adjuvant chemotherapy in older women with breast cancer[J].J Clin Oncol,2006,24(18):2750-2756.
|
| [24] |
Aapro M, Bernard-Marty C, Brain EG, et al. Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper[J]. Ann Oncol,2011,22(2):257-267.
|
| [25] |
Jones SE, Savin MA, Holmes FA, et al. Phase Ⅲ trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast[J]. J Clin Oncol,2006,24(34):5381-5387.
|
| [26] |
NHS CeVEAS, WHO Collaborating Centre for Evidence-Based Research Synthesis and Guideline Development in Reproductive Health. Review of the available evidence on taxanes(paclitaxel and docetaxel) for breast cancer[EB/OL]. [2013-01-09].http:/ /www.who. int/selection_medicines/committees/expert/18/applications/8_submission_taxanes.pdf.
|
| [27] |
Muss HB, Berry DA, Cirrincione CT, et al. Adjuvant chemotherapy in older women with early-stage breast cancer[J]. N Engl J Med,2009,360(20):2055-2065.
|
| [28] |
Oostendorp LJ,Stalmeier PF,Donders AR,et al. Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review[J]. Lancet Oncol,2011,12(11):1053-1061.
|
| [29] |
Pivot X, Romieu G, Bonnefori H, et al. PHARE trial results comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer [EB/OL]. [2013-01-09]. http:/ /abstracts.webges.com/viewing/view.php? congress=esmo2012&congress_ id=370&publication_id=3866.
|
| [30] |
Gelber RD, Goldhirsch A, Piccart M, et al. HERA Trial: 2 years versus 1 year of trastuzumab after adjuvant chemotherapy in women with HER2-positive early breast cancer at 8 years of median follow up[EB/OL]. [2013-01-09]. http:/ /abstracts.webges.com/viewing/view. php? congress=esmo2012&congress_id=370&publication_id=3780.
|
| [31] |
Baselga J, Campone M, Piccart M, et al. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer[J]. N Engl J Med,2012,366(6):520-529.
|
| [32] |
Amir E, Seruga B, Niraula S, et al. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis[J]. J Natl Cancer Inst,2011,103(17):1299-1309.
|
| [33] |
Robertson JF, Llombart-Cussac A, Rolski J, et al. Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer:results from the FIRST study[J]. J Clin Oncol,2009,27(27):4530-4535.
|
| [34] |
Di Leo A, Jerusalem G, Petruzelka L,et al. Results of the CONFIRM phase Ⅲtrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer[J]. J Clin Oncol,2010,28(30):4594-4600.
|
| [35] |
Mehta RS, Barlow WE, Albain KS, et al. Combination anastrozole and fulvestrant in metastatic breast cancer[J]. N Engl J Med,2012,367(5):435-444.
|
| [36] |
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials[J]. Lancet,2005,366(9503):2087-2106.
|
| [37] |
Hughes K, Schnaper l, Cirrincione C, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer [J]. J Clin Oncol,2010,28(suppl):507.
|
| [38] |
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG).Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials[J]. Lancet,2011,378(9804):1707-1716.
|
| [39] |
Shah C, Antonucci JV, Wilkinson JB, et al. Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis[J]. Radiother Oncol,2011,100(2):210-214.
|
| [40] |
Khan AJ, Vicini FA, Beitsch P, et al. Local control, toxicity,and cosmesis in women ＞70 years enrolled in the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial[J]. Int J Radiat Oncol Biol Phys,2012,84(2):323-330.
|
| [41] |
Smith BD, Haffty BG, Hurria A, et al. Postmastectomy radiation and survival in older women with breast cancer[J]. J Clin Oncol,2006,24(30):4901-4907.
|
| [42] |
Lee JC, Truong PT, Kader HA, et al. Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer[J]. Clin Oncol (R Coll Radiol),2005,17(8):623-629.
|